Drug Trial Radar · NCT02958215
Phenylephrine and Hypotension During Spinal Anesthesia for Cesarean Section
Last checked: Nov 20, 2026Latest source record: May 18, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
980
Actual
Start
Jun 2016
Primary completion
May 2017
Study completion May 2017
Sponsor
- Lead sponsor
- Assiut UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 8, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Pregnant women with a positive preoperative Supine stress test were found to be a subgroup at increased risk of symptomatic hypotension after spinal anesthesia
Conditions
- Anesthesia, Obstetrical
- Anesthesia, Spinal
Interventions
PhenylephrineDrug
it will be given as a prophylaxis for prevention of hypotension after spinal anesthesia in pregnant patients undergoing cesarean section
PlaceboOther
5 ml normal saline will be given before spinal anesthesia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of hypotensionTime frame: within first 24 hours after spinal anesthesia
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Faculty of Medicine
Asyut, Egypt
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.